Lin28b Mediated Ikk-Beta Sustains The Stemness Of Breast Cancer Stem Cell Via Regulating Wnt/Tcf4 And Mir-34a/Lef1 Signaling Pathway
chong chen,l bai,fengqi cao,yan liu,j xie,wei wang,qin si,jian yang,antao chang,rong xiang,yunping luo
DOI: https://doi.org/10.1158/1538-7445.AM2014-3046
IF: 11.2
2014-01-01
Cancer Research
Abstract:Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA
Substantial evidence indicates that many human cancers are driven by a subpopulation of cells that display stem cell properties. These cancer stem cells (CSCs) may also contribute to tumor metastasis and treatment resistance. It has been reported that inflammatory factors in tumor microenvironment activate NF-kB/IKK-β pathway in tumor cells which in turn drive CSC self-renewal, but their molecular basis remain unclear. In this study, we demonstrated a novel mechanism regarding that Lin28B, a RNA binding protein regulated by IKK-β, sustains the stemness of breast cancer stem cell via regulating Wnt/TCF4 and miR-34a/LEF1 signaling pathway. First, we found that all stemness properties of MDA-MB-231 human breast cancer cells including ALDH+ population, Sphere-forming ability and the expression of stemness genes SOX2, OCT4, NANOG and Lin28B were decreased by IKK-β inhibition, meanwhile, the down regulated expression of Lin28B decrease the stemness properties of MDA-MB-231 cells as well. Furthermore, it was found that Wnt/TCF4 signaling pathway was inhibited by Lin28B down-regulation via reducing the expression of TCF4. Interestingly, TCF4 could also regulate the expression of Lin28B by directly binding to the intron 1 of Lin28B. Moreover, we observed that microRNA-34a was down regulated by Lin28B at transcriptionally level, and increased miR34a expression inhibited the activity of Wnt/LEF1 pathway by directly targeting LEF1. Most importantly, we found that down regulated expression of Lin28B or IKK-β inhibition combined with chemo-drug (IKK-β selective inhibitor IMD-0354 combine with paclitaxel) could markedly suppressed tumor growth and metastasis of MDA-MB-231 breast tumor cells in NOD/SCID mice model. Taken together, our study demonstrated that Lin28B, which was activated by IKK-β, could sustain the stemness of CSC via the TCF4 and miR-34a/LEF1 signaling regulation, thus, establish the Lin28B as a central regulator in govern inflammation to maintain breast cancer stemness phenotype, and could serve as a therapeutical target.
Citation Format: Chong Chen, Lipeng Bai, Fengqi Cao, Yan Liu, Junling Xie, Wei Wang, Qin Si, Jian Yang, Antao Chang, Rong Xiang, Yunping Luo. Lin28B mediated IKK-β sustains the stemness of breast cancer stem cell via regulating Wnt/TCF4 and miR-34a/LEF1 signaling pathway. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3046. doi:10.1158/1538-7445.AM2014-3046